You have 9 free searches left this month | for more free features.

elsulfavirine fixed-dose combination

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastro-Oesophageal Cancer Trial in Worldwide (Regorafenib, Nivolumab, Docetaxel)

Recruiting
  • Gastro-Oesophageal Cancer
  • Scottsdale, Arizona
  • +74 more
Jan 11, 2022

Mesothelioma Trial in Durham, Houston (Durvalumab / tremelimumab, Platinum cisplatin or carboplatin and pemetrexed chemo plus

Not yet recruiting
  • Mesothelioma
  • Durvalumab / tremelimumab
  • Platinum cisplatin or carboplatin and pemetrexed chemotherapy plus durvalumab/tremelimumab
  • Durham, North Carolina
  • +1 more
Jul 5, 2023

Meningococcal Infections Trial in Finland (MenACYW conjugate vaccine)

Completed
  • Meningococcal Infections
  • MenACYW conjugate vaccine
  • Espoo, Finland
  • +7 more
Mar 24, 2022

Suicidal Ideation, Suicide Attempt Trial (CAMS Single Session Consultation, Driver Focused Skills Training, Caregiver Skills

Not yet recruiting
  • Suicidal Ideation
  • Suicide Attempt
  • CAMS Single Session Consultation
  • +3 more
  • (no location specified)
Aug 15, 2023

NSCLC Trial in Worldwide (Nivolumab, Ipilimumab)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Nivolumab
  • Ipilimumab
  • Springdale, Arkansas
  • +34 more
May 2, 2022

Lymphangioleiomyomatosis Trial in Milan (Nintedanib)

Completed
  • Lymphangioleiomyomatosis
  • Milan, Italy
    Pneumology unit
Sep 26, 2022

Metastatic Castration-Resistant Prostate Cancer Trial in United States (XmAb20717 + carboplatin + cabazitaxel, XmAb20717 +

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • XmAb20717 + carboplatin + cabazitaxel
  • +2 more
  • Duarte, California
  • +9 more
May 24, 2022

Advanced Melanoma, Tumor Infiltrating Lymphocyte, Treatment Side Effects Trial in Shanghai (Tumor Infiltrating Lymphocyte)

Recruiting
  • Advanced Melanoma
  • +3 more
  • Tumor Infiltrating Lymphocyte
  • Shanghai, China
    Shanghai Tenth People's Hospital
Dec 19, 2022

Multiple Myeloma, Relapse Multiple Myeloma Trial in Bethesda, Madison (Descartes-25)

Recruiting
  • Multiple Myeloma
  • Relapse Multiple Myeloma
  • Shreveport, Louisiana
  • +3 more
Nov 4, 2022

Chronic Pain, Opioid Use, Analgesia Trial in Bronx (TapPro)

Enrolling by invitation
  • Chronic Pain
  • +2 more
  • TapPro
  • Bronx, New York
    Montefiore Medical Center
May 4, 2022

Gastric Adenocarcinoma, Metastatic Adenocarcinoma of the Gastroesophageal Junction Trial in Germany (Ramucirumab, TAS 102)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Metastatic Adenocarcinoma of the Gastroesophageal Junction
  • Frankfurt, Germany
  • +4 more
Mar 2, 2022

Recurrent DLBCL Activated B-Cell Type, Recurrent DLBCL Germinal Center B-Cell Type, Recurrent High Grade B-Cell Lymphoma With

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type
  • +8 more
  • Biospecimen Collection
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 8, 2023

Chronic Rhinosinusitis (Diagnosis) Trial in Darlinghurst (Betamethasone Dipropionate Nasal Cream 0.0644%, Pre-filled syringe and

Recruiting
  • Chronic Rhinosinusitis (Diagnosis)
  • Betamethasone Dipropionate Nasal Cream 0.0644%
  • Pre-filled syringe and applicator device
  • Darlinghurst, New South Wales, Australia
    Sydney Ear Nose and Throat Clinic Pty Ltd
Sep 19, 2022

Tumor Malignant Trial in Worldwide (SAR245408, SAR245409)

Completed
  • Neoplasm Malignant
  • Birmingham, Alabama
  • +20 more
Mar 30, 2022

Total Shoulder Athroplasty Trial in New York (Tranexamic Acid Injection)

Recruiting
  • Total Shoulder Athroplasty
  • Tranexamic Acid Injection
  • New York, New York
    NYU Langone Health
Jul 7, 2022

Chemo-induced Peripheral Neuropathy Trial (N Acetylcysteine A, N Acetylcysteine B)

Not yet recruiting
  • Chemotherapy-induced Peripheral Neuropathy
  • N Acetylcysteine A
  • N Acetylcysteine B
  • (no location specified)
Sep 12, 2022

Chronic Kidney Disease Trial (HRS-1780 table or )

Not yet recruiting
  • Chronic Kidney Disease
  • HRS-1780 table or placebo
  • (no location specified)
Dec 5, 2022

Herpes Zoster Trial in Bengbu (PEGIFNa1b, Placebo)

Completed
  • Herpes Zoster
  • Bengbu, Anhui, China
    The first affiliated hospital of bengbu medical college
Nov 28, 2022

Urinary Bladder, Overactive, Urodynamics, Effect of Drug Trial in Taipei (Intradetrusor Botox® (onabotulinumtoxinA) injection,

Recruiting
  • Urinary Bladder, Overactive
  • +2 more
  • Intradetrusor Botox® (onabotulinumtoxinA) injection
  • Combine Mirabegron and Solifenacin.
  • Taipei, Taiwan
    Mackay Memorial Hospital
Jul 29, 2023

Healthy Trial (RE02, Manitol)

Not yet recruiting
  • Healthy
  • (no location specified)
Jul 31, 2023

Spinal Cord Injury Trial in Chicago (drug, other, behavioral)

Recruiting
  • Spinal Cord Injury
  • Chicago, Illinois
    Shirley Ryan Abilitylab
Jul 6, 2022

Postoperative Retention of Urine Trial in Evanston (Tamsulosin, Placebo)

Not yet recruiting
  • Postoperative Retention of Urine
  • Evanston, Illinois
    NorthShore University Health System
Mar 6, 2023

Parkinson's Disease Trial in Peoria, Bingham Farms (Sinemet 25-100 Oral Tablet, XP21279, Carbidopa Pill)

Completed
  • Parkinson's Disease
  • Sinemet 25-100 Oral Tablet
  • +2 more
  • Peoria, Arizona
  • +1 more
Apr 30, 2021

Healthy Trial in Randwick (CSL324, Placebo)

Completed
  • Healthy
  • CSL324
  • Placebo
  • Randwick, Australia
    Scientia Clinical Research Ltd
Oct 3, 2022

NSCLC NSCLC Trial in Worldwide (Durvalumab, Placebo for Olaparib, Olaparib)

Active, not recruiting
  • Non-small Cell Lung Cancer NSCLC
  • Bonita Springs, Florida
  • +67 more
Nov 15, 2022